CML & PH+ All: There is so much more to know CML & PH+ All: There is so much more to know Explore
Think | Test | Treat

WHAT IS THINK
TEST TREAT?

The THINK TEST TREAT programme was initiated by Incyte to raise awareness of the importance of regular and sensitive monitoring and mutation testing in patients with Ph+ leukaemias

Read more

CML

Why is It important to think about regular BCR-ABL1 monitoring and mutation testing when treating patients with CML?

Read more

Ph+ ALL

Why is it important to monitor minimal residual disease and test for mutations when treating patients with Ph+ ALL?

Read more

For further information, please contact Incyte Medical Information: eumedinfo@incyte.com